Winder, T., Zhang, W., Yang, D., Ning, Y., Bohanes, P., Gerger, A., . . . Lenz, H. (2010). Germline polymorphisms in genes involved in the IGF1-pathway predict efficacy of cetuximab in wild-type KRAS mCRC patients.
Chicago Style citaatWinder, Thomas, et al. Germline Polymorphisms in Genes Involved in the IGF1-pathway Predict Efficacy of Cetuximab in Wild-type KRAS MCRC Patients. 2010.
MLA citatieWinder, Thomas, et al. Germline Polymorphisms in Genes Involved in the IGF1-pathway Predict Efficacy of Cetuximab in Wild-type KRAS MCRC Patients. 2010.
Let op: Deze citaties zijn niet altijd 100% accuraat.